The effects of sacubitril/valsartan compared to valsartan in experimentally induced chronic kidney disease. [PDF]
Al Maskari R +4 more
europepmc +1 more source
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial. [PDF]
Solomon SD +11 more
europepmc +1 more source
Cardiorenal protective effects of dapagliflozin combined with valsartan in patients with type 2 diabetes mellitus and hypertension: a retrospective cohort study. [PDF]
Zhou Z, Gong K.
europepmc +1 more source
Sacubitril/valsartan as a modulator of pulmonary fibrosis: insights into Lnc-SNHG-16/miR-455 modulation and Notch/Smad-3 pathway inhibition. [PDF]
Abdel-Nasser ZM, Zaafan MA.
europepmc +1 more source
Correction: Short-term effects of sacubitril/valsartan on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease. [PDF]
Saengklub N +4 more
europepmc +1 more source
TangShenWeiNing formula alleviates diabetic kidney disease by inhibiting ferroptosis via AMPK pathway in renal tubular epithelial cells. [PDF]
Jiang Y, Chang J, Guo Y, Liu Z, Feng X.
europepmc +1 more source
Efficacy and Safety of Sacubitril/Valsartan Versus Enalapril in the Treatment of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]
Aljubeh R +6 more
europepmc +1 more source
Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis. [PDF]
Abhari AP +6 more
europepmc +1 more source
Golimumab-Associated Myocarditis with Progressive Eosinophilia after Route Switch in Rheumatoid Arthritis. [PDF]
Ammari S, Ibrahim N.
europepmc +1 more source
Sacubitril/Valsartan Improves Functional Capacity and Reverses LV Remodeling in Obese Patients with Hypertrophic HFpEF: A Randomized Open-Label Study. [PDF]
Ovchinnikov A +7 more
europepmc +1 more source

